We found that pharmacologically blocking AMPARs or genetically blocking TrkB through NTRK2 knockout decreased tumour cell proliferation in vivo or in neuron–glioma co-culture (Fig. 1j–m and Extended Data Fig. 5a,b). The gene discussed is NTRK2; the disease is central nervous system cancer.